Fee for Service vs Value Based Care: The Definitive 2026 Guide for U.S. Healthcare Leaders

Imagine paying a mechanic every single time they touched your car – whether the repair held or not. That’s been the working logic of traditional fee-for-service healthcare for decades. Now, the industry is in the middle of the most consequential payment transformation in its history. And in 2026, there’s no going back.

A $5.3 Trillion Crisis That’s Rewriting the Rules of Healthcare Payment

The numbers are staggering and they’re no longer shocking only to economists.

According to the most recent official data published by the Centers for Medicare & Medicaid Services (CMS) and reported in Health Affairs in January 2026, U.S. healthcare spending grew 7.2% in 2024, reaching $5.3 trillion or $15,474 per person. Health spending now accounts for 18.0% of the nation’s GDP, and federal healthcare spending alone is projected to balloon from $1.9 trillion in 2026 to $3.1 trillion by 2036.

Meanwhile, Medicare’s Hospital Insurance Trust Fund — the financial backbone of the program — is now projected to be depleted by 2040, a full 12 years earlier than projected just one year ago.

This is the fiscal burning platform behind one of healthcare’s most urgent policy debates: fee-for-service (FFS) vs. value-based care (VBC). These aren’t just abstract payment philosophies. They are fundamentally different theories of how American medicine should work, who should be rewarded, and what the system should optimize for.

In 2026, that debate has sharpened considerably. The Trump administration is pushing providers faster toward downside financial risk. The CMS Innovation Center has launched a wave of new mandatory and voluntary models. Marketplace premiums have jumped 26% on average. And hospitals are spending more than ever while margins stay razor-thin.

This is your definitive, data-driven guide to understanding fee for service vs value based care — written for U.S. healthcare leaders who need to make real decisions in a rapidly shifting landscape.

What Is Fee-for-Service Healthcare? The Model That Built Modern American Medicine

Fee-for-service is the original American healthcare payment model. When Medicare launched in 1966 under Parts A and B, it operated on a simple premise: a service rendered equals a payment made. Every physician consultation, every diagnostic test, every surgical procedure triggered a separate billing event and a separate reimbursement.

For decades, this model worked well enough. Medicine was less complex. Costs were manageable. And the administrative technology to track outcomes across populations simply didn’t exist.

But the cracks began to show as the system scaled. More services meant more revenue. More complexity meant more billing codes. More volume meant more spending — regardless of whether any of it actually made patients healthier.

How Fee-for-Service Works in Practice

The mechanics of FFS are straightforward:

• A patient presents to a provider or facility
• The provider delivers a service (an exam, a procedure, imaging, a lab test)
• A claim is submitted using a standardized billing code (CPT code) to the payer — Medicare, Medicaid, or a private insurer
• The payer reimburses a pre-set dollar amount per code
• The provider is paid whether the patient recovers fully, partially, or not at all

There is no built-in financial incentive to prevent illness, coordinate care, reduce readmissions, or manage chronic conditions proactively. The system pays for activity. Period.

The Core Problem: Volume Over Value

Here’s the fundamental dysfunction: under fee-for-service, doing more generates more revenue — regardless of outcomes.

A primary care physician who spends 30 minutes carefully counseling a patient with poorly controlled Type 2 diabetes earns the same — or sometimes less — than one who quickly orders a panel of tests and moves on. A hospital that discharges a surgical patient without adequate post-acute coordination can see that same patient return within 30 days, generating additional revenue.

This perverse incentive structure has fueled:

• Overutilization of low-value services — unnecessary imaging, duplicative lab work, procedures with marginal benefit
• Fragmented care — specialists, hospitals, and primary care operating in silos with poor coordination
• Chronic disease neglect — no financial reward for keeping diabetics, heart failure patients, or asthmatics out of the ED
• Skyrocketing spending — hospital expenses alone grew 7.5% in 2025, more than twice the rate of growth in hospital prices over the same period, per the American Hospital Association

And the 2026 projections make clear this trajectory is unsustainable. CBO estimates higher-than-expected Medicare Part A fee-for-service spending is one of the key drivers behind the accelerated depletion of the Medicare HI Trust Fund — now set to run dry by 2040.

What Is Value-Based Care? The Shift from Activity to Accountability

Value-based care is a healthcare payment and delivery framework in which providers are reimbursed based on the quality of care delivered and the health outcomes achieved, rather than the volume of services provided. The core principle, articulated by Harvard’s Michael Porter, defines value as health outcomes achieved per dollar spent.

Under VBC, if a patient stays healthier, avoids preventable hospitalizations, and achieves better disease control, providers earn more. If outcomes are poor and costs run high, payments are reduced or withheld. The financial incentive is aligned with the clinical goal.

The Value-Based Care Spectrum: The HCPLAN Framework

Value-based care is not a single model — it’s a continuum. The Health Care Payment Learning & Action Network (HCPLAN) defines four levels:

• Level 1 — Pure Fee-for-Service: No quality connection. The traditional model.
• Level 2 — FFS with Quality Reporting: Pay-for-performance bonuses or penalties layered onto FFS. Limited quality linkage.
• Level 3 — Alternative Payment Models (APMs) with Shared Risk: Accountable Care Organizations, bundled payments, shared savings and losses. True accountability.
• Level 4 — Population-Based Payments: Full or global capitation. Providers manage population health for a fixed budget.

When healthcare leaders discuss “moving to value-based care,” they primarily mean Levels 3 and 4 — models where providers share meaningful financial risk tied to outcomes.

The Major Value-Based Care Models Operating in 2026

1. Medicare Shared Savings Program (MSSP) The flagship federal ACO program. Providers coordinate care for a defined Medicare population and share in savings when spending falls below benchmarks while meeting quality standards. Currently the largest alternative payment model in U.S. healthcare.

2. ACO REACH Model Designed for high-performing organizations ready for full two-sided risk. The ACO REACH Model concludes at the end of 2026, and a successor model — LEAD (Longitudinal and Equity-Aligned Delivery) — is being developed as a 10-year program beginning in 2027.

3. Transforming Episode Accountability Model (TEAM) Launched January 1, 2026 as a mandatory five-year model running through December 2030. Selected acute care hospitals are accountable for the total cost of five surgical episodes — including lower extremity joint replacement, spinal fusion, coronary artery bypass graft, surgical hip femur fracture treatment, and major bowel procedures — plus 30 days of post-acute care.

4. ACCESS Model (Advancing Chronic Care through Evidence, Standards, and Solutions) A new voluntary, 10-year model announced in late 2025 and launching in 2026. ACCESS tests outcome-aligned payments for technology-enabled care for beneficiaries with chronic conditions. Critically, ACCESS participants may not bill traditional Medicare FFS claims for aligned beneficiaries — a direct signal that CMS is drawing a harder line between the two models.

5. Bundled Payments for Care Improvement Advanced (BPCI Advanced) A single prospective payment covers all services within a defined care episode. Participating providers absorb savings or losses depending on actual spending vs. the target price.

6. Patient-Centered Medical Homes (PCMH) A team-based primary care model rewarding care coordination, prevention, and chronic disease management — not visit volume.

7. Hospital Value-Based Purchasing (HVBP) Redistributes a percentage of Medicare inpatient payments based on hospital performance scores across quality measures. As of 2024, over 2,900 hospitals participate.

Fee for Service vs Value Based Care: The 2026 Head-to-Head Comparison

Feature	Fee-for-Service	Value-Based Care
Payment Basis	Per service/procedure/visit	Patient outcomes, quality metrics, cost efficiency
Provider Incentive	Higher volume = higher revenue	Better outcomes = higher payment
Primary Focus	Treatment of acute illness	Prevention, chronic management, wellness
Care Coordination	Incidental	Central and financially rewarded
Financial Risk	Payer absorbs all cost risk	Risk shared between payer and provider
Patient Role	Passive recipient of care	Active partner in health management
Technology Needs	Billing and coding systems	EHR analytics, population health platforms, AI tools
Data Requirements	Claims data for billing	Clinical outcomes, quality measures, risk stratification
Cost Predictability	Highly variable, volume-driven	More predictable; tied to population benchmarks
Best Application	Acute, complex, episodic care	Primary care, chronic disease, post-acute management
Long-term Sustainability	Declining — FFS drives unsustainable cost growth	Higher — incentives align with cost control
2026 CMS Policy Direction	Under increasing constraint via site-neutral cuts	Being aggressively expanded through new models

The 2026 Data: Where U.S. Healthcare Payments Stand Right Now

The transformation from fee-for-service to value-based payment is no longer a future aspiration — it’s a documented, measurable reality accelerating in real time. Here is what the most current data shows:

Total healthcare spending: U.S. healthcare spending reached $5.3 trillion in 2024 — up 7.2% from the prior year — and now equals 18.0% of GDP, per CMS’s official National Health Expenditure Accounts data published in January 2026. Medicare spending alone grew 7.8% to $1.118 trillion in 2024, accounting for 21% of total national health expenditures.

Value-based payment adoption:

• As of January 2025 (the most recent official enrollment data), 53.4% of traditional Medicare beneficiaries are in some form of accountable care arrangement — representing more than 14.8 million individuals, a 4.3 percentage point increase year-over-year
• More than 64% of Medicare Advantage payments flowed through value-based arrangements in 2023, up from 58% in 2020
• 28.5% of all U.S. healthcare payments included downside financial risk in 2024, up from 24.5% in 2022, per the HCPLAN annual survey

Medicare Shared Savings Program — Performance Year 2024 (record results):

• 75% of the 476 participating ACOs — serving 10.3 million assigned Medicare beneficiaries — earned performance payments
• Total ACO earnings: $4.1 billion
• Medicare net savings: $2.4 billion relative to benchmarks — the highest savings since the program’s inception in 2012
• Per-capita net savings reached $245 in 2024, up from $207 in 2023
• PY 2024 had the highest share of ACOs receiving performance payments and the highest amount of savings for both ACOs and Medicare in MSSP history

New 2026 model activity:

• The TEAM model launched January 1, 2026 — a mandatory episode-based payment model covering five high-volume surgical procedures
• CMS’s 2026 Physician Fee Schedule proposed rule includes proposals to shorten the time ACOs can remain in one-sided (upside-only) risk tracks, pushing providers toward full accountability faster
• The ACCESS model begins its first cohort in 2026, explicitly prohibiting FFS billing for aligned chronic care patients
• LEAD, the planned successor to ACO REACH, is a 10-year program beginning in 2027

The fiscal pressure intensifying everything:

• Federal healthcare spending is projected to grow from $1.9 trillion in 2026 to $3.1 trillion by 2036 — a 63% increase
• The Medicare Hospital Insurance Trust Fund is projected to be depleted by 2040 — 12 years earlier than estimated just one year ago
• CBO cites higher-than-expected FFS spending as a direct contributor to that accelerated depletion

The message from policymakers in 2026 is unmistakable: the days of fee-for-service as the default are numbered.

The Clinical Evidence: Does Value-Based Care Actually Deliver Better Results?

A landmark study published in JAMA Health Forum in 2025 — one of the most rigorous and large-scale analyses of its kind — examined clinical quality performance across Medicare Advantage members in value-based payment vs. fee-for-service arrangements. The conclusion was definitive: VBP models, particularly those with increased risk-sharing, were associated with significantly superior performance across 15 standardized clinical quality measures covering cancer screening, diabetes management, heart disease, osteoporosis, and care coordination.

Systematic reviews across both public and private sector ACOs have consistently found that value-based models reduce costs without compromising quality, with savings driven by reductions in outpatient spending and avoidance of low-value services. The most consistent findings: meaningful reductions in inpatient admissions and emergency department visits, alongside measurable gains in preventive care and chronic disease management.

Hospitals participating in value-based programs have achieved an average 5.6% reduction in per-patient costs, and ACOs have reported more than $7 billion in cumulative Medicare savings over four years of operation.

Real-World Evidence: Primary Care Transformation Under VBC

Consider two primary care practices in the same city:

Practice A operates under traditional FFS. The physician sees 25 patients a day in 7–8 minute slots. There is no financial incentive to call a high-risk diabetic patient between visits, reconcile medications with a cardiologist, or ensure a COPD patient has an action plan for exacerbation management. Revenue comes from visit volume.

Practice B joins an ACO under MSSP. Suddenly, the financial calculus changes entirely. Every avoided hospitalization generates shared savings. Care coordinators proactively reach out to patients with uncontrolled HbA1c. The EHR flags patients overdue for colorectal cancer screening. A nurse practitioner calls a heart failure patient three days post-discharge to prevent a bounce-back admission.

The result? Practice B sees fewer ER visits, lower hospitalization rates, better blood pressure and diabetes control scores — and earns performance payments that more than offset the investment in care coordination infrastructure. ACOs with at least 75% primary care clinician composition have delivered nearly 30% better per-capita net savings compared with similarly-sized ACOs with mixed specialty composition.

The Real Advantages of Fee-for-Service: A Fair Assessment

It would be intellectually dishonest to dismiss FFS entirely. The model has genuine strengths that explain its durability:

Simplicity and operational clarity. Providers know precisely what they’ll be paid for every code billed. There’s no ambiguity about revenue for services delivered. For complex, high-acuity procedural care — cardiac surgery, trauma, oncology — FFS appropriately compensates the resources actually consumed.

Immediate and predictable short-term cash flow. Services rendered equals claims submitted equals payment processed. For practices without risk infrastructure, this predictability has real value.

Appropriate for certain acute care scenarios. For genuinely unpredictable, episodic, complex interventions — a novel diagnosis, a rare condition, a true trauma case — FFS payment logic is sound. You can’t capitate your way through a Level I trauma center.

Lower barrier to entry for small and independent practices. VBC contracts require data analytics platforms, care coordination staff, and quality reporting infrastructure. Smaller practices — particularly in rural or underserved areas — often lack the capital or workforce to build these systems without external support.

No utilization gatekeeping. Under FFS, patients access services without financial barriers built around utilization management tied to cost benchmarks.

The Compelling Case for Value-Based Care

The evidence in 2026 strongly favors VBC as the more sustainable model for the chronic disease-dominant, resource-constrained U.S. healthcare environment:

Chronic disease management is fundamentally better. When providers are rewarded for keeping patients with diabetes, heart failure, COPD, and hypertension healthy between visits — rather than just treating acute exacerbations — outcomes improve measurably. This matters enormously in a country where chronic conditions account for 90% of the nation’s $5.3 trillion in annual healthcare expenditures.

Reduces wasteful, low-value care. VBC models create financial incentives to eliminate unnecessary imaging, redundant testing, and avoidable procedures — the same services that drive overutilization under FFS. Bundled payment models for joint replacement alone have generated cost savings of 20–30% without degrading outcomes.

Drives true care coordination. VBC financially rewards the kind of connected, team-based, post-acute care management that prevents patients from “falling through the cracks.” This is especially critical for high-utilization Medicare populations managing multiple chronic conditions.

Engages patients as partners. Shared decision-making, wellness visits, patient portals, remote monitoring, and proactive outreach are all rewarded behaviors under VBC — creating a virtuous cycle of engagement, adherence, and better outcomes.

Addresses the root cause of cost growth. The CBO’s 2026 projections are explicit: higher-than-expected FFS spending is accelerating the depletion of the Medicare Trust Fund. VBC isn’t just a quality improvement strategy — it’s a fiscal survival strategy for the Medicare program itself.

The Real Challenges of Transitioning to Value-Based Care

Candor requires acknowledging the significant obstacles standing between aspiration and execution:

The Data and Technology Gap

Effective VBC demands robust data infrastructure: interoperable EHRs, real-time performance dashboards, risk-stratification analytics, and care gap identification tools. Healthcare organizations succeeding under VBC contracts typically invest 3–5% of their annual revenue in technology and staff training. Many smaller practices and rural health systems simply don’t have that capacity — yet.

Financial Risk Exposure for Small Practices

For independent practices without large patient panels, assuming downside financial risk is genuinely dangerous. A single complex patient — advanced cancer, multi-system organ failure — can distort population-level cost metrics. The Medical Group Management Association’s most recent surveys show fewer than half of practice leaders express optimism about their future in value-based care, citing financial risk as the primary concern.

The 2026 FFS Payment Floor Is Eroding

Here’s the cruel irony of 2026: while CMS is pushing providers aggressively toward VBC, it’s simultaneously cutting the FFS floor from under them. CMS’s proposed 2026 Physician Fee Schedule included another round of payment reductions — the sixth consecutive year of overall Medicare physician payment cuts. The 2025 rule cut rates by 2.83%, from $33.29 to $32.35 per unit — and for a practice earning $500,000 from Medicare, that’s $14,150 in lost annual revenue. Meanwhile, hospital expenses grew 7.5% in 2025 and Medicare Part B premiums rose to $203 per month in 2026, up $18 from last year.

Providers are caught in a vise: FFS revenues are declining, but VBC infrastructure costs money to build.

Physician Burnout and Administrative Overload

Quality reporting, care coordination documentation, performance measure tracking — all of this adds administrative weight to already-overburdened clinicians. Without the right EHR workflow integration and support staff, VBC can deepen rather than alleviate the burnout epidemic. Over time, AI-enabled tools promise to reduce this friction — but in 2026, that promise is still being fully realized.

The Timeline Problem

VBC models take time to generate measurable results. Systematic reviews consistently note that it often takes 2–3 years into a VBC contract before savings materialize at scale. Organizations entering risk-bearing contracts need patience, capital reserves, and leadership commitment to weather the transition period.

Technology and AI: The Infrastructure That Makes Value-Based Care Work

Value-based care is, at its core, a data and analytics problem. You cannot manage population health without knowing which patients are high-risk, which care gaps exist, and how your clinical performance compares to benchmarks in real time.

In 2026, artificial intelligence is becoming the great equalizer — potentially lowering the barrier to VBC participation for smaller organizations:

Predictive risk stratification — AI models trained on claims and clinical data can identify patients likely to deteriorate or be hospitalized within the next 30–90 days, enabling proactive outreach before a crisis occurs.

Automated care gap identification — Machine learning tools can mine EHR records to flag patients overdue for cancer screenings, HbA1c testing, medication reconciliation, or wellness visits — directly driving quality measure performance.

Administrative burden reduction — Natural language processing tools are beginning to automate prior authorization workflows, clinical documentation, and quality measure reporting — giving clinicians time back.

Remote patient monitoring integration — VBC models like ACCESS explicitly build in outcome-aligned payments for technology-enabled chronic care. Remote monitoring for hypertension, diabetes, and CHF patients aligns perfectly with the financial incentives of population health management.

States receiving CMS Rural Health Transformation funds in 2026 are actively investing in these technologies — deploying telehealth infrastructure, remote patient monitoring, and AI-assisted clinical decision support as part of their VBC transition strategies.

CMS’s 2026 Policy Agenda: The Full-Court Press on Value

The current administration’s CMS innovation agenda in 2026 is the most active in years. Here’s what healthcare leaders need to track:

TEAM Model (Launched January 1, 2026) The Transforming Episode Accountability Model is now live as a mandatory, five-year program covering surgical episodes at selected acute care hospitals. Hospitals are accountable for all care costs during the episode and 30 days post-hospitalization — a direct assault on the fragmented, FFS-driven post-acute care problem. CMS explicitly designed TEAM to require hospitals to connect patients to primary care services, building long-term accountable care relationships.

2026 Physician Fee Schedule: Accelerating Risk CMS’s proposed 2026 PFS rule contains a significant VBC push: a proposal to shorten the time ACOs can remain in one-sided (upside-only) risk tracks within MSSP. This means providers will face financial consequences — not just bonuses — for poor performance. The Trump administration has been explicit: it wants more downside risk, faster.

Site-Neutral Payment Expansion CMS’s 2026 OPPS rule expands site-neutral payment policy — aligning reimbursements for services delivered in expensive hospital outpatient departments with lower physician office rates. This is expected to save $280 million in 2026 alone, with beneficiaries seeing $70 million in reduced out-of-pocket costs. Broader site-neutral reform could save certain cancer patients more than $1,500 per year.

ACCESS Model — New Chronic Care Payment Architecture The ACCESS model’s first cohort begins in 2026, introducing a radical payment structure: 50% of payment is made quarterly upfront, with the remaining 50% contingent on beneficiaries achieving defined clinical outcomes. FFS billing is explicitly excluded for aligned patients. This is the clearest signal yet that CMS is building a parallel payment architecture for chronic care that has no room for fee-for-service logic.

LEAD Model (Beginning 2027) The planned successor to ACO REACH is already attracting attention. LEAD introduces a 10-year time horizon, capitated population-based payments, and broad eligibility including FQHCs and rural providers. Applications begin in spring 2026. Organizations evaluating LEAD alongside their MSSP strategy need to move now.

What Does the Future of Fee for Service vs Value Based Care Look Like?

The trajectory is clear, even if the path is bumpy:

More mandatory models, fewer voluntary options. The CMS Innovation Center’s 2026 slate includes multiple mandatory models — TEAM being the highest-profile. Providers no longer have the luxury of waiting on the sidelines while early adopters test the waters.

Downside risk becomes the norm, not the exception. The era of upside-only VBC contracts — where providers could earn bonuses but face no penalties — is ending. CMS’s 2026 PFS proposals and the broader policy environment are accelerating the shift to full two-sided accountability.

Primary care as the anchor of the system. Every data point reinforces the same conclusion: ACOs and VBC models led by primary care outperform those that aren’t. CMS’s 2026 payment rules explicitly attempt to redirect more funding toward primary care services. The organizations that invest in primary care infrastructure today are building the backbone of tomorrow’s VBC success.

AI will democratize population health management. As AI tools become more affordable and EHR-integrated, the data analytics capabilities that today require large health systems will become accessible to independent practices and rural providers. This could finally crack open VBC participation for the long tail of smaller organizations.

Social determinants of health go mainstream. The next generation of VBC models will integrate housing, nutrition, transportation, and mental health — the upstream factors responsible for the overwhelming majority of health outcomes. States are already deploying Rural Health Transformation funds toward these whole-person care investments in 2026.

The FFS model doesn’t disappear — it gets constrained. Fee-for-service won’t vanish overnight. But CMS’s site-neutral payment expansions, mandatory episode models, and ACO acceleration are systematically reducing the scope where pure FFS logic applies. By 2030, FFS as we knew it in 2010 will be largely unrecognizable.

Conclusion: The Burning Platform Has a Name and It’s $5.3 Trillion

The fee-for-service vs. value-based care debate has moved from theoretical to existential in 2026.

With U.S. healthcare spending at $5.3 trillion and rising 7.2% per year, the Medicare Trust Fund accelerating toward insolvency by 2040, and CMS launching the most aggressive slate of new VBC models in program history, American healthcare leaders no longer have the luxury of treating payment model transformation as a future agenda item.

Fee-for-service built the modern American hospital system. It funded generations of brilliant physicians and drove extraordinary advances in medical technology. And for acute, complex, episodic care, it still has a role to play.

But as the dominant logic of a system overwhelmed by chronic disease, unsustainable cost growth, and fractured care delivery — FFS has failed. The MSSP’s record 2024 results ($4.1 billion in ACO earnings, $2.4 billion in Medicare savings), the clinical quality evidence from JAMA, and CMS’s relentless policy direction in 2026 all point the same direction.

Value-based care is not a trend. It is the architecture of American healthcare’s future. The organizations that build toward that future — investing in data infrastructure, care coordination capacity, physician alignment, and population health management — will define the next era of U.S. healthcare leadership.

Your 2026 Value-Based Care Readiness Checklist

Whether you lead a health system, a physician group, a payer organization, or a healthcare startup, here are your immediate action items:

1. Audit your payment mix today. What share of your revenue is VBC vs. FFS? Where is your greatest financial exposure as FFS rates continue to decline?
2. Evaluate your MSSP or ACO strategy for 2026–2027. MSSP application cycles are open. LEAD applications begin in spring 2026. Don’t miss these windows.
3. Assess TEAM model exposure. If your hospital performs any of the five covered surgical procedures in a selected CBSA, you are mandatory — not optional — in TEAM. Understand your episode cost baseline now.
4. Invest in your data infrastructure. You cannot improve what you don’t measure. EHR analytics, risk stratification, and quality reporting are table stakes — not competitive advantages — in 2026.
5. Plan your downside risk transition. CMS is shortening the runway for upside-only tracks. Model your financial exposure under two-sided risk now, before your contract forces the issue.
6. Engage your physicians. Physician buy-in remains the single most important predictor of VBC success. Invest in clinical leadership education, aligned incentive structures, and transparent performance sharing.

The future of American healthcare is outcome-driven, accountability-based, and data-enabled. The payment model that serves that future is not fee-for-service. And in 2026, the window for passive observation is officially closed.